Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,076
Closed -$305K 199
2019
Q3
$305K Buy
3,076
+225
+8% +$21.4K 0.05% 145
2019
Q2
$264K Sell
2,851
-550
-16% -$52.2K 0.04% 155
2019
Q1
$321K Hold
3,401
0.06% 122
2018
Q4
$218K Sell
3,401
-51
-1% -$3.77K 0.05% 90
2018
Q3
$309K Hold
3,452
0.06% 83
2018
Q2
$274K Hold
3,452
0.08% 83
2018
Q1
$307K Sell
3,452
-91
-3% -$8.74K 0.09% 75
2017
Q4
$370K Sell
3,543
-507
-13% -$57.2K 0.1% 68
2017
Q3
$590K Hold
4,050
0.18% 50
2017
Q2
$526K Hold
4,050
0.17% 51
2017
Q1
$504K Buy
4,050
+250
+7% +$29.9K 0.16% 48
2016
Q4
$440K Sell
3,800
-231
-6% -$25.7K 0.14% 53
2016
Q3
$421K Buy
4,031
+31
+0.8% +$3.35K 0.14% 78
2016
Q2
$395K Sell
4,000
-80
-2% -$8.28K 0.13% 78
2016
Q1
$408K Buy
4,080
+220
+6% +$22.7K 0.15% 73
2015
Q4
$462K Sell
3,860
-40
-1% -$4.63K 0.17% 72
2015
Q3
$422K Hold
3,900
0.18% 69
2015
Q2
$451K Buy
3,900
+136
+4% +$15.5K 0.18% 69
2015
Q1
$434K Sell
3,764
-391
-9% -$46.7K 0.18% 66
2014
Q4
$465K Buy
4,155
+63
+2% +$6.64K 0.19% 66
2014
Q3
$388K Hold
4,092
0.16% 70
2014
Q2
$351K Buy
4,092
+730
+22% +$55.5K 0.15% 76
2014
Q1
$235K Buy
3,362
+30
+0.9% +$2.38K 0.1% 86
2013
Q4
$282K Sell
3,332
-1,548
-32% -$122K 0.12% 77
2013
Q3
$376K Buy
4,880
+50
+1% +$3.5K 0.18% 67
2013
Q2
$283K Buy
+4,830
New +$291K 0.14% 71

Other funds holding CELG

BRR OpCo's CELG Position: Q4 2019 in Review

BRR OpCo sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,076 shares — an estimated $305K sold.

BRR OpCo first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $590K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BRR OpCo reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BRR OpCo sold 3,076 Celgene Corp shares in Q4 2019, an estimated $305K.
  • BRR OpCo first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • BRR OpCo's Celgene Corp position peaked at $590K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BRR OpCo's 13F filing for Q4 2019, filed 31 Jan 2020.